Project Grant R21HL188514
Award Date 8/14/26
Completion Date 7/31/28
Dollars Obligated $114K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Arlington, TX 76019, USA
Similar Awards
- The National Heart, Lung, and Blood Institute awarded The University of Texas Southwestern Medical Center $246,000 on August 5, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to investigate sex-specific differences in subclinical cardiovascular disease phenotypes and their relationship to psychosocial stress. The recipient will develop expertise in subclinical atherosclerosis measures and cardiovascular imaging phenotypes while examining whether chronic psychosocial...
- The National Heart, Lung, and Blood Institute of the Department of Health and Human Services awarded Texas A&M Agrilife Research $787,642 on August 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to evaluate the impact of pay-what-you-can restaurants on coronary heart disease-related outcomes among hypertensive, food-insecure individuals. The research will conduct a prospective natural experiment and mixed-methods process evaluation across two pay-what-you-can cafes...
- The National Institutes of Health National Heart, Lung, and Blood Institute awarded The University of Texas Southwestern Medical Center $150,104 on March 2, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to investigate cardiovascular and respiratory responses to physical activity and heat stress in burn survivors. The recipient will conduct research on thermoregulation and pulmonary function impairment in burn survivors, who experience exaggerated increases in core...
- The National Heart, Lung, and Blood Institute awarded the University of Texas Health Science Center at Houston $794,406 on July 1, 2026, for a Project Grant (R01HL181234) to optimize and evaluate an implementation strategy to improve use of classroom-based physical activity approaches in elementary schools. This award is funded under the Cardiovascular Diseases Research program (CFDA 93.837). The recipient will develop and refine a multifaceted implementation strategy designed to promote two...
- The National Heart, Lung, and Blood Institute awarded The University of Texas Southwestern Medical Center $608,173 on July 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to investigate the role of the stretch-activated PIEZO1 channel in heart failure-associated atrial fibrillation. The research comprises three aims: testing the hypothesis that atrial stretch-induced PIEZO1 activation contributes to pathological atrial remodeling and atrial fibrillation predisposition...
- The National Heart, Lung, and Blood Institute awarded the University of Texas at Arlington $579,745 on July 25, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to develop deep learning-based reconstruction (DRAC) methods for multi-phase cardiac CT angiography. The project runs through June 30, 2029, with performance at the university's Arlington, Texas campus. The award funds development of four-dimensional deep learning reconstruction algorithms that combine model-based...
- The National Heart, Lung, and Blood Institute awarded the University of Texas at Austin $238,858 on September 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to develop personalized prediction models for HER2-induced cardiovascular adverse events in older women with breast cancer using artificial intelligence and machine learning. The award funds a cohort study using 2011–2022 Surveillance, Epidemiology, and End Results (SEER)–Medicare data linked with American...
- The National Heart, Lung, and Blood Institute awarded Texas Tech University $594,288 on August 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to investigate YAP/TAZ signaling pathways in vascular smooth muscle cell adhesion and migration as a preventive and therapeutic strategy for atherosclerosis. The research comprises three aims. Aim 1 will define how extracellular matrix mechanics regulate vascular smooth muscle cell mechanotransduction. Aim 2 will assess how...
- The National Heart, Lung, and Blood Institute awarded the University of Texas Health Science Center at Houston $153,063 on September 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to develop and evaluate a multi-component implementation strategy for increasing physical activity in pre-kindergarten classrooms. The recipient will develop classroom-based physical activity interventions—specifically physical activity breaks (PABs) and physically active lessons...
- The National Institute for Minority Health and Health Disparities awarded the University of Texas at Arlington $1,316,481 under the Minority Health and Health Disparities Research program (CFDA 93.307) on June 29, 2026. The project develops a measurement instrument to assess daily experiences of social stress and their immediate psychological and behavioral effects, and investigates associations between stress-related daily social experiences and risks of hypertension and cardiovascular disease....